Figure 6.1 Examples of small-molecule and peptide neurotransmitters

Figure 6.1 Examples of small-molecule and peptide neurotransmitters (Part 1)

Figure 6.1 Examples of small-molecule and peptide neurotransmitters (Part 2)

Figure 6.1 Examples of small-molecule and peptide neurotransmitters (Part 3)

Figure 6.2 Acetylcholine metabolism in cholinergic nerve terminals

Box 6A Neurotoxins that Act on Postsynaptic Receptors

Figure 6.3 The structure of the nACh receptor/channel

Figure 6.3 The structure of the nACh receptor/channel (Part 1)

Figure 6.3 The structure of the nACh receptor/channel (Part 2)

Figure 6.4 The general architecture of ligand-gated receptors

Figure 6.4 The general architecture of ligand-gated receptors (Part 1)

Figure 6.4 The general architecture of ligand-gated receptors (Part 2)

Figure 6.4 The general architecture of ligand-gated receptors (Part 3)

Box 6B Myasthenia Gravis

Figure 6.5 Structure and function of metabotropic receptors

Figure 6.5 Structure and function of metabotropic receptors (Part 1)

Figure 6.5 Structure and function of metabotropic receptors (Part 2)

Figure 6.6 Glutamate synthesis and cycling between neurons and glia

Figure 6.7 NMDA and AMPA/kainate receptors

Figure 6.7 NMDA and AMPA/kainate receptors (Part 1)

Figure 6.7 NMDA and AMPA/kainate receptors (Part 2)

Figure 6.7 NMDA and AMPA/kainate receptors (Part 3)

Figure 6.8 Synthesis, release, and reuptake of the inhibitory neurotransmitters GABA and glycine

Figure 6.8 Synthesis, release, reuptake of inhibitory neurotransmitters GABA and glycine (Part 1)

Figure 6.8 Synthesis, release, reuptake of inhibitory neurotransmitters GABA and glycine (Part 2)

Figure 6.9 Ionotropic GABA receptors

Figure 6.9 Ionotropic GABA receptors (Part 1)

Figure 6.9 Ionotropic GABA receptors (Part 2)

Box 6D Excitatory Actions of GABA in the Developing Brain

Box 6D Excitatory Actions of GABA in the Developing Brain (Part 1)

Box 6D Excitatory Actions of GABA in the Developing Brain (Part 2)

Box 6D Excitatory Actions of GABA in the Developing Brain (Part 3)

Figure 6.10 The biosynthetic pathway for the catecholamine neurotransmitters

Figure 6.10 The biosynthetic pathway for the catecholamine neurotransmitters (Part 1)

Figure 6.10 The biosynthetic pathway for the catecholamine neurotransmitters (Part 2)

Figure 6.10 The biosynthetic pathway for the catecholamine neurotransmitters (Part 3)

Figure 6.10 The biosynthetic pathway for the catecholamine neurotransmitters (Part 4)

Figure 6.10 The biosynthetic pathway for the catecholamine neurotransmitters (Part 5)

Figure 6.11 Neurons and their projections containing catecholamine neurotransmitters

Figure 6.11 Neurons and their projections containing catecholamine neurotransmitters (Part 1)

Figure 6.11 Neurons and their projections containing catecholamine neurotransmitters (Part 2)

Figure 6.11 Neurons and their projections containing catecholamine neurotransmitters (Part 3)

Figure 6.12 Distribution of neurons and their projections containing histamine or serotonin

Figure 6.12 Distribution of neurons and their projections containing histamine or serotonin (Part 1)

Figure 6.12 Distribution of neurons and their projections containing histamine or serotonin (Part 2)

Figure 6.13 Synthesis of histamine and serotonin

Figure 6.13 Synthesis of histamine and serotonin (Part 1)

Figure 6.13 Synthesis of histamine and serotonin (Part 2)

Figure 6.14 Proteolytic processing of the pre-propeptides pre-proopiomelanocortin and pre-proenkephalin A

Figure 6.14 Proteolytic processing of the pre-propeptides pre-proopiomelanocortin and pre-proenkephalin A (Part 1)

Figure 6.14 Proteolytic processing of the pre-propeptides pre-proopiomelanocortin and pre-proenkephalin A (Part 2)

Figure 6.15 Neuropeptides usually contain between 3 and 36 amino acids

Box 6G Marijuana and the Brain

Figure 6.16 Endocannabinoid signals involved in synaptic transmission

Figure 6.16 Endocannabinoid signals involved in synaptic transmission (Part 1)

Figure 6.16 Endocannabinoid signals involved in synaptic transmission (Part 2)

Figure 6.16 Endocannabinoid signals involved in synaptic transmission (Part 3)

Figure 6.17 Endocannabinoid-mediated retrograde control of GABA release

Figure 6.17 Endocannabinoid-mediated retrograde control of GABA release (Part 1)

Figure 6.17 Endocannabinoid-mediated retrograde control of GABA release (Part 2)

Figure 6.17 Endocannabinoid-mediated retrograde control of GABA release (Part 3)

Figure 6.18 Synthesis, release, and termination of NO